Aadi Bioscience, Inc.AADINASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+52.6%
5Y CAGR+6.2%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+52.6%/yr
vs -23.2%/yr prior
5Y CAGR
+6.2%/yr
Recent acceleration
Acceleration
+75.8pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 64.30% |
| Q2 2025 | -259.76% |
| Q1 2025 | 19.69% |
| Q4 2024 | -41.27% |
| Q3 2024 | 13.93% |
| Q2 2024 | 20.13% |
| Q1 2024 | -10.15% |
| Q4 2023 | 0.76% |
| Q3 2023 | 8.68% |
| Q2 2023 | -16.17% |
| Q1 2023 | -8.76% |
| Q4 2022 | -2.89% |
| Q3 2022 | 18.10% |
| Q2 2022 | -32.91% |
| Q1 2022 | 13.36% |
| Q4 2021 | 81.74% |
| Q3 2021 | -1729.90% |
| Q2 2021 | -9.32% |
| Q1 2021 | -151.93% |
| Q4 2020 | 415.58% |
| Q3 2020 | 47.64% |
| Q2 2020 | -58.76% |
| Q1 2020 | 11.68% |
| Q4 2019 | 26.38% |
| Q3 2019 | 2.62% |
| Q2 2019 | 42.68% |
| Q1 2019 | 0.45% |
| Q4 2018 | -179.13% |
| Q3 2018 | 285.61% |
| Q2 2018 | 19.26% |
| Q1 2018 | -18.89% |
| Q4 2017 | -32.22% |
| Q3 2017 | 14.82% |
| Q2 2017 | -17.32% |
| Q1 2017 | -29486.53% |
| Q4 2016 | -270.67% |
| Q3 2016 | 14.95% |
| Q2 2016 | 99.88% |
| Q1 2016 | -43647.46% |
| Q4 2015 | -122.11% |